Rs. 27 to Rs. 30 Grey Market Premium Signals Strong Investor Interest
ABH Healthcare Limited, a growing multi-specialty healthcare provider operating under the brand name “Anil Baghi Hospital”, announced the opening of its Initial Public Offering. The Issue will open for subscription on Monday, August 24, 2026 and will close on Thursday, August 27, 2026. The Company is proposed to be listed on the NSE SME platform. The Issue Price Band has been fixed at Rs. 96 to Rs. 102 per equity share and the total Issue Size is Rs. 34.98 crore.
- Issue Opens: August 24, 2026
- Issue Closes: August 27, 2026
- Face Value: Rs 10
- Price Band: Rs 96 – 102 per share
- Minimum Bid Lot: 1200 Equity Shares
- Listing: NSE SME
The IPO comprises a fresh issue of 34,29,600 equity shares of face value Rs. 10 each through the book building process. The application lot size is 1,200 equity shares. The Issue includes a Market Maker Reservation of 1,72,800 equity shares, while the Net Issue to the Public is 32,56,800 equity shares.
Adding to the positive market interest around the IPO, ABH Healthcare is commanding a strong premium in the unofficial grey market ahead of the issue opening. The offline grey market premium is currently indicated at around Rs. 27 to Rs. 30 per share against the upper price band of Rs. 102 per share. This represents an indicative premium of approximately 26.5% to 29.4% over the issue price, highlighting strong market interest in the IPO ahead of its opening.
The Company proposes to utilise Rs. 17.00 crore towards repayment or prepayment, in part or full, of certain borrowings and Rs. 5.00 crore towards funding its working capital requirements. Further, a portion of the Net Proceeds will be utilised towards funding inorganic growth through unidentified acquisitions and general corporate purposes.
ABH Healthcare has strengthened its financial performance over the last three years, with profitability growing at a significantly faster pace than revenue. Consolidated revenue grew from Rs. 41.38 crore in FY24 to Rs. 52.51 crore in FY26, while EBITDA more than doubled from Rs. 6.89 crore to Rs. 14.72 crore and Profit After Tax increased over threefold from Rs. 1.66 crore to Rs. 5.64 crore during the same period. This improvement is also reflected in the Company’s EBITDA margin, which expanded from 16.66% in FY24 to 28.03% in FY26. The Company’s FY26 performance highlights its ability to translate revenue growth into stronger operating profitability, with ROE standing at 39.07% for the year.
With rising healthcare expenditure, growing awareness around specialised treatment and increasing demand for organised healthcare services, India’s healthcare sector continues to offer significant growth opportunities. ABH Healthcare is positioned to build on its established institutional network, participation in key government healthcare schemes and diversified service offerings to expand its presence across the healthcare services market and create long term value for its stakeholders.
